XOM
42
-6
PG
50
2
HIG
66
2
OMC
50
-16
VMC
53
-4
EMR
71
-3
BSX
64
-3
AIZ
82
2
FSLR
44
-2
PCAR
56
-5
IR
63
-3
ISRG
71
-5
GILD
47
-8
MAS
52
-4
GM
74
5
EFX
30
-8
FE
44
5
AMT
37
3
XYL
35
-2
OXY
36
-2
XOM
42
-6
PG
50
2
HIG
66
2
OMC
50
-16
VMC
53
-4
EMR
71
-3
BSX
64
-3
AIZ
82
2
FSLR
44
-2
PCAR
56
-5
IR
63
-3
ISRG
71
-5
GILD
47
-8
MAS
52
-4
GM
74
5
EFX
30
-8
FE
44
5
AMT
37
3
XYL
35
-2
OXY
36
-2
Financhill
Back

Investcorp Europe Acquisition Corp I Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
35

IVCB
Investcorp Europe Acquisition Corp I

Last Price:
11.52
Seasonality Move:
1.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
35
Investcorp Europe Acquisition Corp I (IVCB) is a Sell

Is Investcorp Europe Acquisition Corp I a Buy, Sell or Hold?

  • The current Investcorp Europe Acquisition Corp I [IVCB] share price is $11.52. The Score for IVCB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • IVCB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVCB Stock Price Chart

What is Investcorp Europe Acquisition Corp I's stock price today?

  • The Investcorp Europe Acquisition Corp I share price today is $11.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVCB is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

IVCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 35.61 Sell
Chaikin Money Flow: -1748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.54 - 12) Sell
Bollinger Bands (100): (11.32 - 11.76) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

IVCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.54 Sell
20-day SMA: 11.77 Sell
50-day SMA: 11.7 Sell
200-day SMA: 11.4 Buy
8-day EMA: 11.57 Sell
20-day EMA: 11.67 Sell
50-day EMA: 11.67 Sell
200-day EMA: 11.41 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Investcorp Europe Acquisition Corp I Earnings Growth & IVCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Investcorp Europe Acquisition Corp I Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):